Nox2 Oxidase Activity Accounts for the Oxidative Stress and Vasomotor Dysfunction in Mouse Cerebral Arteries Following Ischemic Stroke
Overview
Affiliations
Background And Purpose: Post-ischemic oxidative stress and vasomotor dysfunction in cerebral arteries may increase the likelihood of cognitive impairment and secondary stroke. However, the underlying mechanisms of post-stroke vascular abnormalities, as distinct from those causing primary brain injury, are poorly understood. We tested whether augmented superoxide-dependent dysfunction occurs in the mouse cerebral circulation following ischemia-reperfusion, and evaluated the role of Nox2 oxidase.
Methods: Cerebral ischemia was induced in male C57Bl6/J wild-type (WT) and Nox2-deficient (Nox2(-/-)) mice by middle cerebral artery occlusion (MCAO; 0.5 h), followed by reperfusion (23.5 h). Superoxide production by MCA was measured by L-012-enhanced chemiluminescence. Nitric oxide (NO) function was assessed in cannulated and pressurized MCA via the vasoconstrictor response to N(ω)-nitro-L-arginine methyl ester (L-NAME; 100 µmol/L). Expression of Nox2, the nitration marker 3-nitrotyrosine, and leukocyte marker CD45 was assessed in cerebral arteries by Western blotting.
Results: Following ischemia-reperfusion, superoxide production was markedly increased in the MCA of WT, but not Nox2(-/-) mice. In WT mice, L-NAME-induced constriction was reduced by ∼50% in ischemic MCA, whereas ischemia-reperfusion had no effect on responses to L-NAME in vessels from Nox2(-/-) mice. In ischemic MCA from WT mice, expression of Nox2 and 3-nitrotyrosine were ∼1.4-fold higher than in the contralateral MCA, or in ischemic or contralateral vessels from Nox2(-/-) mice. Vascular CD45 levels were unchanged by ischemia-reperfusion.
Conclusions: Excessive superoxide production, impaired NO function and nitrosative stress occur in mouse cerebral arteries after ischemia-reperfusion. These abnormalities appear to be exclusively due to increased activity of vascular Nox2 oxidase.
Lochhead J, Ronaldson P, Davis T Biochem Pharmacol. 2024; 228:116186.
PMID: 38561092 PMC: 11410550. DOI: 10.1016/j.bcp.2024.116186.
Wu X, Ji D, Wang Z, Yu W, Du Q, Hu W Neuropsychiatr Dis Treat. 2023; 19:1027-1042.
PMID: 37153352 PMC: 10155717. DOI: 10.2147/NDT.S407907.
Common Shared Pathogenic Aspects of Small Vessels in Heart and Brain Disease.
Moretti R, Janjusevic M, Fluca A, Saro R, Gagno G, Pierri A Biomedicines. 2022; 10(5).
PMID: 35625746 PMC: 9138783. DOI: 10.3390/biomedicines10051009.
Hendricks K, To E, Luong R, Liong F, Erlich J, Shah A Front Cell Infect Microbiol. 2022; 12:883448.
PMID: 35601109 PMC: 9115386. DOI: 10.3389/fcimb.2022.883448.
Small Vessel Disease: Ancient Description, Novel Biomarkers.
Moretti R, Caruso P Int J Mol Sci. 2022; 23(7).
PMID: 35408867 PMC: 8998274. DOI: 10.3390/ijms23073508.